John Paulson joins Valeant’s board after his firm took a nearly $2 billion hit on Valeant

John Paulson, one of the widest known names in the hedge fund world, will be joining the board of Valeant Pharmaceuticals, the drug company announced Monday morning. Paulson became a director of the board on June 14, Valeant said. “We are pleased to welcome John...